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Research
Bisphenol A (BPA) is one of the highest-
production-volume chemicals, with > 6 bil-
lion pounds produced worldwide each year 
(Vandenberg et al. 2010). BPA is used pri-
marily to manufacture polycarbonate plas-
tic and epoxy resins, which can be used in 
impact-resistant safety equipment and baby 
bottles, as protective coatings in metal food 
containers, and as composites and sealants in 
dentistry (European Union 2003; National 
Toxicology Program 2008). BPA can also 
be used in the processing of polyvinyl chlo-
ride plastic and thermal paper (National 
Toxicology Program 2008).
Because of its extensive use, human expo-
sure to BPA is widespread. Data from the 
2003–2004 National Health and Nutrition 
Examination Survey (NHANES) conducted 
by the Centers for Disease Control and 
Prevention (CDC) showed that 92.6% of 
individuals sampled among the U.S. gen-
eral population had detectable levels of BPA 
in their urine (Calafat et al. 2008). Results 
from many other studies also have shown 
BPA exposure in different population groups 
(Becker et al. 2009; Braun et al. 2009; Calafat 
et al. 2008; He et al. 2009; Health Canada 
2010; Lee et al. 2008; Matsumoto et al. 2003; 
Teitelbaum et al. 2008; Völkel et al. 2008, 
2011; Wolff et al. 2007; Yang et al. 2009; Ye 
et al. 2005b).
BPA exposure is thought to result pri-
marily from ingesting food (World Health 
Organization 2010). Upon exposure, BPA is 
rapidly metabolized and eliminated in urine. 
Metabolism includes phase II biotransfor-
mations, which result in the formation of 
conjugated species (e.g., glucuronides and sul-
fates). The total (free plus conjugated) urinary 
concentration of BPA is a valid biomarker of 
exposure to BPA (Calafat et al. 2008), and 
several biomonitoring efforts have evaluated 
BPA exposure by using spot urine speci-
mens (Calafat et al. 2005, 2008; CDC 2011; 
Health Canada 2010; Matsumoto et al. 2003; 
Yang et al. 2003).
Because of the short half-life of BPA 
(about 6 hr) (Völkel et al. 2002), spot urinary 
BPA concentrations primarily reflect expo-
sure within a relatively short period preceding 
urine collection (Koch and Calafat 2009). 
Furthermore, background exposure to BPA is 
likely to be episodic (e.g., ingestion of meals) 
and variable in magnitude. As a result, there 
is considerable within-person and between-
person temporal variability of BPA con-
centrations in spot urine samples (Arakawa 
et al. 2004; Mahalingaiah et al. 2008; 
Nepomnaschy et al. 2009; Teitelbaum et al. 
2008), and hourly variability of BPA urinary 
concentrations can be expected. To the best 
of our knowledge, no data are available to 
address this within-day BPA variability in 
spot urine specimens. Furthermore, because 
diet, which often changes daily, is thought 
to be the main pathway of exposure to BPA 
(World Health Organization 2010), data on 
the variability of urinary BPA concentrations 
measured from 24-hr and first morning voids 
would also be of scientific interest. However, 
to date, no studies have addressed either 
within-day variability or variability in BPA 
urinary concentrations of spot samples, first 
morning voids, or 24-hr collections obtained 
from the same person. To address these data 
gaps, we present here the variability in BPA 
urinary concentrations from eight adults with 
no known occupational BPA exposure who 
collected a total of 427 urine specimens for 
7 consecutive days while performing their 
regular activities.
Materials and Methods
Urine collection. From October through 
November 2005, a group of four male and 
four female CDC employees in Atlanta, 
Georgia, provided urine samples. The group 
participated in a study designed to examine 
temporal variability in the urinary concen-
trations of polycyclic aromatic hydrocarbon 
(PAH) metabolites (Li et al. 2010). The study 
participants were nonsmoking volunteers 
between 26 and 58 years of age who had 
no documented occupational PAH or BPA 
exposure. The institutional review board of 
CDC approved the study, and all participants 
signed an informed consent.
For a 1-week study period, the eight par-
ticipants collected a total of 427 samples, 
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Ba c k g r o u n d: Human exposure to bisphenol A (BPA) is widespread. After exposure, BPA is rapidly 
metabolized and eliminated in urine. Therefore, there is considerable within-person and between-
person variability of BPA concentrations in spot urine samples. However, no information exists on 
the within-day variability of urinary BPA concentrations.
oBjectives: We examined the between-person and within-person and between-day and within-
day variability in the urinary BPA concentrations of eight adults who collected all voids for 1 week 
to investigate the impact of sampling strategy in the exposure assessment of BPA using spot, first 
morning, or 24-hr urine collections.
Me t h o d s : We determined the urinary concentrations of BPA using on-line solid-phase extraction 
coupled to isotope dilution high-performance liquid chromatography/tandem mass spectrometry.
re s u l t s: The between-day and within-person variability was the primary contributor to the total 
variance both for first morning voids (77%) and 24-hr urine collections (88%). For the spot collec-
tions, we observed considerable within-day variance (70%), which outweighed the between-person 
(9%) and between-day and within-person (21%) variances.
co n c l u s i o n s: Regardless of the type of void (spot, first morning, 24-hr collection), urinary BPA 
concentrations for a given adult changed considerably—both within a day and for the 7 days of the 
study period. Single 24-hr urine collections accurately reflect daily exposure but can misrepresent 
variability in daily exposures over time. Of interest, when the population investigated is sufficiently 
large and samples are randomly collected relative to meal ingestion times and bladder emptying 
times, the single spot–sampling approach may adequately reflect the average exposure of the popu-
lation to BPA.
key w o r d s : biomonitoring, bisphenol A, BPA, exposure, human, urine, variability. Environ Health 
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including 56 first morning voids, and missed 
collecting 23 samples [see Supplemental 
Material, Table 1 (doi:10.1289/ehp.1002701)]. 
Each participant collected every urine void in a 
commercial, nonvinyl, nonpolycarbonate plas-
tic specimen collection cup. After recording the 
volume of each void, the urine was decanted in 
a prelabeled, sterile urine cup and stored in an 
ice cooler. The urine samples were retrieved 
from participants daily (or after the weekend), 
aliquoted into polypropylene cryovials or glass 
jars, and stored at –70°C until analysis. During 
the study week, participants also were asked to 
record food and drink intake, medications con-
sumed (if any), driving (all participants com-
muted by car 10–50 miles during the work 
week), and other activities.
Analytical method for measuring BPA. 
The total BPA concentration was measured 
using a mass spectrometry method described 
previously (Ye et al. 2005a). The limit of 
detection (LOD) was 0.4 µg/L. To ensure 
data accuracy and precision, each batch of 
samples included quality control (QC) sam-
ples, standards, and reagent blanks. The QC 
concentrations were evaluated using standard 
statistical probability rules (Caudill et al. 
2008). Urinary creatinine, used to correct 
the dilution of the urine, was measured at 
CDC using a Roche Hitachi 912 Chemistry 
Analyzer (Hitachi, Pleasanton, CA).
Statistical analysis. We performed the 
statistical analyses using SAS software (SAS 
Institute Inc., Cary, NC). For concentra-
tions below the LOD, we used a value equal 
to the LOD divided by the square root of 2 
(Hornung and Reed 1990). The urinary BPA 
concentration followed a log-normal distribu-
tion. Thus, before statistical analysis, all data 
were log10 transformed.
The first morning void was defined as 
the first sample collected by each person at 
or after 5:00 a.m. each day. The simulated 
24-hr void concentration was calculated based 
on the volume-weighted average of all urine 
samples collected (missed collections were not 
accounted for) during a 24-hr period start-
ing after midnight. To assess the impact of 
creatinine adjustment on the total variance 
when exposure is categorized from the BPA 
concentrations of spot urine samples, we built 
three different models. For model A, BPA was 
not creatinine-corrected (log10 non  corrected 
concentration in micrograms per liter), 
whereas for model B, BPA was creatinine-
  corrected to account for urinary dilution 
(log10 creatinine-corrected concentration in 
micrograms per gram creatinine). Model C 
adjusted for urine dilution by including crea-
tinine as a model covariate (log10-adjusted 
concentration in micrograms per liter). We 
ranked these models based on their Akaike 
information criterion (AIC; Akaike 1974) 
(the lower the AIC, the better the model). 
To assess the temporal variability in BPA 
concentrations of spot samples, first morning 
voids, and simulated 24-hr voids, we calcu-
lated intraclass correlation coefficients (ICCs) 
using a three-level model. Level 1 is the time 
(i), which is irregular, unequal, and interval 
nested within the day (level 2, j = 7), which 
is nested within the participants (level 3, 
k = 8). The equation for models A and B was 
Yijk = (Y000) + (V00k + U0jk + γijk), where Yijk 
(the dependent variable) is the log10 (BPA) 
(for model A) or log10 (creatinine-corrected 
BPA) (for model B) for participant k on day j 
at time i. The equation for model C includes 
creatinine as an additional independent vari-
able, with log10 (BPA) as the dependent vari-
able. The intercept Y000 is the grand mean 
(i.e., the average value across all observations), 
and V00k, U0jk, and γijk are the random errors 
for level 3, level 2, and level 1 residual, respec-
tively (Singer 1998). The ICC indicates the 
temporal reproducibility of repeated measures 
Table 1. BPA urinary geometric mean (GM) concentrations for all spot urine samples, first morning voids, 
and simulated 24-hr urine samples.a
Frequency of 
BPA detection (%) 
Concentrations (µg/L) 
[creatinine-corrected (µg/g)]
Type of void GM Median
Spot samples (n = 427) 91 2.8 (4.2) 1.7 (2.7)
First morning voids (n = 56) 100 2.7 (3.5) 2.3 (2.8)
Simulated 24-hr voids (n = 56) 100 2.8 (3.7) 2.4 (3.3)
aFor comparison purposes, for adults (n = 951) from 2003–2004 NHANES (Calafat et al. 2008), the GM and median con-
centrations were 2.6 µg/L (2.4 µg/g) and 2.7 µg/L (2.4 µg/g), respectively. 
Table 2. BPA concentrations of spot urines, first morning voids, and simulated 24-hr urine voids from each participant during the study week.a,b
BPA urinary concentrations of participant (µg/g creatinine)
Week day Void type P1 P2 P3 P4 P5 P6 P7 P8
Monday Spot collection 5.5 (4.9) 3.8 (2.5) 5.0 (4.3) 14.2 (8.9) 3.1 (1.5) 5.0 (0.9) 1.4 (0.9) 5.6 (0.8)
First morning void 1.2 2.0 6.0 5.1 3.2 3.7 0.3 1.7
24-hr void 4.8 4.0 4.4 11.8 2.9 4.8 1.5 3.7
Tuesday Spot collection 2.3 (1) 6.4 (4.7) 2.2 (0.9) 3.7 (1.3) 2.9 (1.7) 2.9 (1) 1.1 (0.6) 3.4 (1.8)
First morning void 1.4 2.7 2.4 3.0 3.7 4.6 0.7 6.0
24-hr void 2.5 5.9 2.1 4.0 2.8 3.1 1.1 4.0
Wednesday Spot collection 2.1 (0.4) 6.3 (2.3) 4.6 (3.2) 3.2 (1.1) 2.9 (1.2) 6.1 (4.5) 2.1 (0.7) 1.4 (0.3)
First morning void 1.5 8.3 0.9 2.2 2.2 1.9 3.1 1.6
24-hr urine 2.2 5.9 3.8 2.8 2.7 3.7 2.5 1.5
Thursday Spot collection 5.3 (4.1) 4.1 (1.8) 5.0 (2.1) 4.5 (3.4) 2.2 (1.4) 6.8 (4.3) 5.4 (2.8) 1.6 (0.7)
First morning void 1.0 3.0 3.0 2.4 3.2 3.4 2.0 1.4
24-hr void 3.9 3.5 4.1 3.9 2.4 5.0 6.6 1.6
Friday Spot collection 7.2 (6) 3.4 (2.1) 3.2 (1.4) 3.4 (3.5) 1.4 (0.6) 6.4 (1.8) 3.4 (0.3) 8.1 (5.1)
First morning void 2.2 2.5 3.9 2.0 1.7 9.0 3.6 0.6
24-hr void 7.0 2.7 3.0 2.9 1.7 6.8 3.3 6.1
Saturday Spot collection 2.7 (1.2) 5.1 (3.1) 3.6 (2.3) 2.8 (2.2) 1.7 (1) 3.2 (3.1) 4.1 (2.7) 1.5 (0.4)
First morning void 5.0 1.5 4.1 1.6 1.0 2.7 0.5 1.1
24-hr void 3.2 3.9 4.0 2.4 1.4 3.1 3.9 1.4
Sunday Spot collection 1.6 (0.6) 3.0 (0.8) 20.1 (35.5) 5.6 (5.6) 2.7 (1.7) 2.2 (0.6) 1.6 (0.7) 0.8 (0.3)
First morning void 0.4 4.2 6.1 1.9 3.2 2.4 1.2 0.6
24-hr void 1.3 3.4 16.6 3.7 2.5 2.3 1.9 0.7
Monday–Sundayc Spot collection 4.0 (4.2) 4.7 (3.0) 6.4 (15.1) 5.0 (5.3) 2.4 (1.5) 4.6 (3.1) 2.6 (2.2) 3.5 (3.8)
First morning void 2.0 (2.4) 3.9 (2.1) 3.2 (2.2) 1.9 (1.4) 4.9 (3.2) 5.3 (2.8) 2.9 (2.8) 3.9 (4.4)
24-hr void 3.6 (1.8) 4.0 (1.0) 5.4 (4.6) 4.5 (3.0) 2.4 (0.5) 4.1 (1.4) 3.0 (1.8) 2.7 (1.8)
aFor the spot samples, the values are the arithmetic mean concentrations of all samples collected daily from each participant. bThe number in parenthesis by the mean concentration 
of the spot collections is the SD. cFor Monday through Sunday, the values are the mean ± SD concentrations of all spot, first morning voids, or 24-hr urine samples collected from each 
participant during 1 week.Variability in urinary BPA levels
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and is computed by dividing the estimate of 
the between-subject variance by the estimated 
total variance. ICC ranges from 0 (poor 
reproducibility) to 1 (perfect reproducibility).
For the spot urine samples, we also com-
pared the variance apportionment of BPA 
and creatinine concentrations by construct-
ing a model in which creatinine concentra-
tion was the outcome. We also checked the 
effect of the missed collections on the varia-
tion pattern of urinary BPA in spot samples 
by comparing the variance apportionment 
of urinary BPA concentrations in spot sam-
ples with and without participant 2, who had 
the largest number of missed collections [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002701)].
Results
Table 1 lists the noncorrected and creati-
nine-corrected geometric mean (GM) and 
median urinary BPA concentrations of the 
spot, first morning, and simulated 24-hr 
urine voids, along with the frequency of BPA 
detection. The creatinine-corrected GMs of 
spot urine samples, first morning voids, and 
simulated 24-hr urine samples ranged from 
3.5 µg/g to 4.2 µg/g. The creatinine-corrected 
median BPA concentrations ranged from 
2.7 µg/g to 3.3 µg/g. We detected BPA in 
91% of the spot samples. Table 2 lists the 
daily average BPA concentrations (in micro-
grams per gram creatinine) estimated from 
each participant’s spot, first morning, and 
simulated 24-hr urine voids during the study 
week. We observed that the daily urinary 
BPA concentrations were occasionally nor-
mally distributed, but not consistently for 
any participant [see Supplemental Material, 
Table 2 (doi:10.1289/ehp.1002701)]. 
Figure 1 shows the BPA concentrations [in 
log10 scale (micrograms per gram creatinine)] 
for all of the spot urine samples collected by 
each of the eight participants over 1 week. 
All participants collected urine samples from 
Monday through Sunday except participant 
3, who collected the urine from Saturday to 
the following Friday. No clear exposure pat-
tern of BPA was observed throughout the 7 
days of collection for the eight participants. 
However, for each person, the urinary BPA 
concentrations could vary up to two orders of 
magnitude within a given day. For example, 
for participant 3 on Sunday, BPA urinary 
concentrations in spot samples varied from 
1.3 µg/g to 117.7 µg/g (Figure 1). As a result, 
the within-day coefficient of variation (CV%) 
from spot urine measurements ranged from 
9% to 177%. We also observed considerable 
variation in the within-person and within-
day BPA concentrations for the first morning 
and simulated 24-hr urine voids (Table 2). In 
any given day, the BPA urinary concentra-
tions from first morning and simulated 24-hr 
urine collections could be rather different, 
even for the same person [e.g., participant 8 
on Friday: 0.6 µg/g (first morning) and 6.1 
µg/g (24-hr collection)]. Table 2 also lists 
the mean   creatinine-corrected urinary BPA 
concentrations of spot, first morning, and 
simulated 24-hr voids from each participant 
averaged over the entire study period. The 
within-person variation CV% in BPA urinary 
concentrations ranged from 63% to 235% 
(spot collections), 53% to 120% (first morn-
ing voids), and 25% to 85% (simulated 24-hr 
voids). For each participant, we also calculated 
the daily total BPA exposure (in micrograms 
per day) during the study period by sum-
ming the amounts of BPA [in micrograms, 
obtained by multiplying the BPA concentra-
tions (in micrograms per liter) in each spot 
urine sample by the spot urine volume (in 
liters)] excreted in one given day (Table 3). 
Of interest, we observed considerable within-
person and between-days variation for BPA 
total daily exposure, with CV% ranging from 
23% (participant 5) to 97% (participant 3).
We used three different models to evalu-
ate how accounting for urine dilution might 
affect BPA concentrations in spot samples 
(Table 4). Model A, without creatinine cor-
rection for urinary dilution, gave the high-
est AIC value (480.1), which indicated the 
worst fit of the three models. AIC was simi-
lar for the models that accounted for the 
dilution of the urine either by dividing the 
BPA concentrations by the creatinine con-
centration (model B, AIC = 268.8) or by 
using creatinine as a covariate in the model 
(model C, AIC = 288.6). We did not observe 
a clear pattern of creatinine excretion among 
Figure 1. Concentration of BPA in log10 scale (µg/g creatinine) for all of the spot urine samples collected 
from eight participants over 1 week.
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Table 3. Total daily exposure (micrograms) to BPA calculated from the BPA concentrations in the spot 
urine samples collected from eight participants during the study week.a
Total daily exposure of participant (µg)
Day P1 P2 P3 P4 P5 P6 P7 P8
Monday 5.9 3.3 4.4 9.5 4.1 7.6 3.6 4.4
Tuesday 3.1 4.3 1.7 7.0 5.6 5.2 1.8 6.5
Wednesday 2.8 5.2 3.9 3.6 5.8 6.1 3.3 1.9
Thursday 5.5 4.7 4.0 4.6 5.8 8.1 13.0 2.3
Friday 8.7 2.5 3.0 3.8 3.4 11.3 5.2 11.0
Saturday 3.9 3.7 4.6 2.0 3.2 4.9 4.4 2.0
Sunday 1.5 1.2 19.7 4.0 4.5 3.8 4.5 1.1
Mean
(Monday–Sunday)a 4.5 ± 2.2 3.5 ± 1.3 5.9 ± 5.7 4.9 ± 2.3 4.6 ± 1.1 6.7 ± 2.3 5.1 ± 3.4 4.2 ± 3.2
aMean ± SD of the total daily exposure of BPA from Monday through Sunday.Ye et al.
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the participants [Supplemental Material, 
Figure 1 (doi:10.1289/ehp.1002701)]. In 
addition, the results of the model in which 
creatinine concentration was the outcome sug-
gested that the variance patterns of creatinine 
and BPA concentrations were similar [see 
Supplemental Material, Table 3 (doi:10.1289/
ehp.1002701)]. However, the differences 
in urine dilution still explained some of the 
observed variance in BPA concentrations of 
the spot samples, because when we accounted 
for urine dilution, the model fits improved 
(models B and C vs. A). Therefore, for all 
subsequent variance calculations, we used 
the creatinine-corrected concentrations (in 
micrograms per gram creatinine).
Table 5 lists the contribution to the total 
variance of the log-transformed creatinine-
corrected concentration of BPA between per-
sons and within persons in 7 consecutive days 
of sampling for all spot, first morning, and 
simulated 24-hr voids. For the spot collec-
tions, the within-day variation was the main 
contributor (70%) to the variance, followed 
by between-day (21%) and between-person 
(9%) variability. Results were comparable 
when participant 2, who missed 14 urine 
collections, was excluded from the analysis 
(Table 5). For the first morning voids, the 
within-person variability (77%) outweighed 
the between-participants variability (23%). 
Similarly, for the simulated 24-hr urine col-
lections, the within-participants’ variance 
contribution (88%) was higher than the 
between-person variance (12%).
Discussion
The BPA creatinine-corrected concentrations 
from the spot urine samples collected for this 
study were of the same order of magnitude 
as those reported for 2003–2004 NHANES 
adults (Calafat et al. 2008), with similar 
median and GM concentrations. Furthermore, 
the BPA detection frequency in the spot urine 
samples collected from our study population 
(91%) was similar to the frequency of detec-
tion from NHANES 2003–2004 (92.6%), 
which was also based on spot sample con-
centrations. Although our study population 
was limited in size, our findings suggest that 
exposure to BPA, estimated from the urinary 
concentrations in spot samples from the adults 
we examined, fell within the reference ranges 
reported for the general U.S. adult population.
Temporal variability in urinary BPA con-
centrations is likely due to changing exposure 
throughout the day and across days, driven by 
the diet and other lifestyle choices of the per-
son. A few studies have investigated the tem-
poral variability of urinary BPA (Aikawa et al. 
2004; Braun et al. 2011; Mahalingaiah et al. 
2008; Nepomnaschy et al. 2009; Teitelbaum 
et al. 2008). Large within-person variabil-
ity appeared in urinary BPA measurements 
of three first morning voids collected from 
60 premenopausal women during approxi-
mately 4 weeks (Nepomnaschy et al. 2009). 
Other studies also indicated the temporal 
within-person and between-person variance 
in urinary BPA concentrations from differ-
ent populations of children and adults over 
periods ranging from days to months (Aikawa 
et al. 2004; Braun et al. 2011; Mahalingaiah 
et al. 2008; Teitelbaum et al. 2008). We also 
observed relatively low between-person ICCs 
(0.09–0.23) for the creatinine-corrected BPA 
concentrations of spot, first morning, and 
simulated 24-hr urine collections. This find-
ing was in agreement with the results reported 
from two previous studies of 35 children who 
collected up to 159 spot urine samples for 
> 6 months (ICC = 0.35) (Teitelbaum et al. 
2008) and of 389 women who provided three 
spot samples during pregnancy and at birth 
(ICC = 0.11) (Braun et al. 2011). These results 
suggest a high within-person variation and a 
rather low reproducibility of the BPA con-
centrations among repeated urine collections 
from the same person. Similar within-person 
and within-day variance has been observed for 
other compounds such as some PAHs (Li et al. 
2010) and di(2-ethylhexyl) phthalate (DEHP) 
(Preau et al. 2010).
As  stated,  human  BPA  exposure 
occurs mainly through diet (World Health 
Organization 2010), which may be highly vari-
able among adults. We observed rather high 
between-day variance for each participant for 
the first morning (77%) and simulated 24-hr 
(88%) urine voids. We also observed a high 
within-person and between-day variance in 
the total daily exposure to BPA estimated from 
the BPA concentrations in spot samples. Of 
interest, the U.S. Environmental Protection 
Agency (1996) has recommended 24-hr urine 
collection for evaluating exposure to pesticides 
and other toxic chemicals excreted primarily 
through urine. Similarly, many epidemiologic 
studies have used the first morning urine void 
because of its correlation with 24-hr urine 
(Kissel et al. 2005; Scher et al. 2007). Still, 
depending on the exposure source of the target 
compound, the considerably high between-
day variance of the 24-hr urine collections 
and the high variance of the total daily expo-
sure mean that collecting 24-hr urine voids 
from a person only once might not be the 
best approach to estimate exposure of this 
person throughout a period of days, weeks, 
or months. Furthermore, given the consider-
able differences in BPA urinary concentra-
tions between the first morning and 24-hr 
voids that we observed for some participants 
on any given day, first morning voids may not 
be good surro  gates for 24-hr collections, at 
least in specific cases (e.g., a first morning void 
collected after having conducted an activity 
associated with exposure to BPA, such as con-
suming a BPA-rich meal, the night before).
Table 5. The variance apportionment of the log-transformed creatinine-corrected concentration of BPA in urine samples collected from eight people over a 
1-week period.
Spot urine collectiona First morning urine voids 24-hr urine void
Variance parameter
Variance 
component
Percentage of 
total variance
Variance 
component
Percentage of 
total variance
Variance 
component
Percentage of 
total variance
Between persons 0.0117 9 0.0234 23 0.0070 12
Within person/between days) 0.0267 21 0.0796 77 0.0521 88
Within person/within day) 0.0902 70
aThe variance component (percentage of total variance) of urinary concentrations of BPA in spot urine samples without participant 2 who had the most missing spot samples was 
0.0103 (7%; between persons), 0.0296 (22%; within person and between days), and 0.0973 (71%; within person and within day).
Table 4. Effect of creatinine correction in the variance apportionment for the urinary concentrations of BPA in spot urine samples collected from eight persons 
over a 1-week period.
Model Aa Model Bb Model Cc
Variance parameter
Variance 
component
Percentage of 
total variance
Variance 
component
Percentage of 
total variance
Variance 
component
Percentage of 
total variance
Between persons 0.0281 14 0.0117 9 0.0090 7
Within person/between days 0.0244 12 0.0269 21 0.0264 20
Within person/within day 0.1536 74 0.0902 70 0.0945 73
aModel A: log10 of BPA concentration as the outcome without creatinine adjustment (AIC = 480.1). bModel B: log10 of creatinine-corrected BPA concentration as the outcome (AIC = 
268.8). cModel C: log10 of BPA concentration as the outcome using creatinine as covariate (AIC = 288.6).Variability in urinary BPA levels
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The mean urinary BPA concentrations 
calculated from the spot urine samples col-
lected by each participant during 1 week 
were closer to the mean concentrations of 
24-hr collections than to the first morning 
void concentrations. However, we observed 
notable within-day variations of BPA con-
centrations in spot urine samples collected 
from the same participant. This high within-
day variability from spot urine samples was 
not unexpected because of the nature of the 
exposure (e.g., episodic ingestion of meals) 
and rapid urinary elimination of BPA. Of 
interest, for the spot collections, was that the 
within-day variability was the major contribu-
tor to the total variance and outweighed both 
the between-person and the between-day and 
within-person contributions. Although some 
persons missed collecting several voids, we did 
not observe much difference in the variance 
pattern of the BPA concentrations from spot 
urine samples based on a sensitivity analysis 
in which we excluded participant 2 who had 
the most missing samples. Nonetheless, our 
results suggest that for a given participant, the 
urinary concentrations of BPA can change 
considerably throughout the day. Thus, at 
a minimum, we recommend recording the 
time of day of urine collection and of the last 
urination. Depending on the diet, which for 
an adult normally varies not only from day to 
day, but also from meal to meal, the timing of 
sample collection relative to the time of food 
consumption and previous bladder-voiding 
times has a direct impact on the estimated 
exposure to BPA based on the concentrations 
of BPA in spot specimens. More important, 
our findings are in close agreement with those 
reported for DEHP, another compound for 
which diet is a main exposure source, where 
the within-day variance was the major con-
tributor of the total variance for spot urine 
specimens (Preau et al. 2010).
Our findings reemphasize the importance 
of sampling strategies during the design of 
an epidemiological study. Such strategies 
should be tailored to the study population. 
For eample, age that may also affect exposure 
to environmental chemicals, including BPA. 
Behavior, diet, and potentially age-related dif-
ferences in metabolism, among other factors, 
likely contribute to BPA exposure. Thus, some 
of the findings we report for this group of 
eight adults may not apply to children, preg-
nant women, and other adult groups of differ-
ent ages. Even though timing and frequency 
of the sampling should depend mainly on the 
route of uptake of the parent compound and 
the half-life of the excreted metabolites, our 
data suggest that when multiple collections 
of spot urine samples over a period of time 
(e.g., days, weeks, months) are logistically and 
economically possible, the samples should 
be randomly collected relative to the times a 
meal is ingested and and the times a bladder 
is emptied.
Conclusions
Exposure variability over time is an important 
factor for interpreting BPA biomonitoring 
data for risk assessment (Vandenberg et al. 
2010). We present here the variability in the 
urinary concentrations of BPA from samples 
collected from eight adults for a period of 7 
consecutive days. Our data suggest that the 
within-person and between-day variability 
was notably higher than the between-person 
contribution for the urinary BPA concentra-
tions obtained from first morning voids and 
24-hr urine collections. More important, we 
observed a significant within-day variance in 
BPA urinary concentrations of spot samples 
collected from the same person. Single 24-hr 
urine collections accurately reflect daily expo-
sure but cannot represent variability in daily 
exposures over time. Therefore, collecting 
one 24-hr urine sample per person will not 
eliminate the potential for exposure misclas-
sification, because such an approach would 
not account for daily variability in exposure. 
Single spot samples, including first morning 
voids, will not eliminate the potential for 
a person’s exposure misclassification either. 
However, when samples are collected from 
a large number of persons (e.g., population 
surveys like NHANES) and randomly col-
lected relative to meal ingestion times and 
bladder emptying times, the single spot–sam-
pling approach may adequately reflect the 
average exposure of a population to BPA. 
Despite the limitations associated with the 
temporality of urinary measures of BPA and 
other nonpersistent chemicals, biomonitor-
ing measures will considerably strengthen an 
exposure   assessment.
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